What is the relevance of bioinformatics to pharmacology?

被引:26
作者
Whittaker, PA [1 ]
机构
[1] Novartis Resp Res Ctr, Horsham RH12 5AB, W Sussex, England
关键词
D O I
10.1016/S0165-6147(03)00197-4
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Although bioinformatics achieved prominence because of its central role in genome data storage, management and analysis, its focus has shifted as the life sciences exploit these data. In pharmacology, genomic, transcriptomic and proteomic data are being used in the quest for drugs that fulfill unmet medical needs, are disease modifying or curative and are more effective and safer than current drugs. Bioinformatics is used in drug target identification and validation and in the development of biomarkers and toxicogenomic and pharmacogenomic tools to maximize the therapeutic benefit of drugs. Now that the 'parts list' of cellular signalling pathways is available, integrated computational and experimental programmes are being developed, with the goal of enabling in silico pharmacology by linking the genome, transcriptome and proteome to cellular pathophysiology.
引用
收藏
页码:434 / 439
页数:6
相关论文
共 75 条
[1]   Toxicology and genetic toxicology in the new era of "toxicogenomics": impact of "-omics" technologies [J].
Aardema, MJ ;
MacGregor, JT .
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2002, 499 (01) :13-25
[2]   Challenges for biomedical informatics and pharmacogenomics [J].
Altman, RB ;
Klein, TE .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2002, 42 :113-133
[3]   Genomic interrogation of mechanism(s) underlying cellular responses to toxicants [J].
Amin, RP ;
Hamadeh, HK ;
Bushel, PR ;
Bennett, L ;
Afshari, CA ;
Paules, RS .
TOXICOLOGY, 2002, 181 :555-563
[4]   Microarrays: the use of oligonucleotides and cDNA for the analysis of gene expression [J].
Barrett, JC ;
Kawasaki, ES .
DRUG DISCOVERY TODAY, 2003, 8 (03) :134-141
[5]   The Molecular Biology Database Collection: 2003 update [J].
Baxevanis, AD .
NUCLEIC ACIDS RESEARCH, 2003, 31 (01) :1-12
[6]   Pharmacogenomic analysis: Correlating molecular substructure classes with microarray gene expression data [J].
Blower P.E. ;
Yang C. ;
Fligner M.A. ;
Verducci J.S. ;
Yu L. ;
Richman S. ;
Weinstein J.N. .
The Pharmacogenomics Journal, 2002, 2 (4) :259-271
[7]   High-throughput crystallography for lead discovery in drug design [J].
Blundell, TL ;
Jhoti, H ;
Abell, C .
NATURE REVIEWS DRUG DISCOVERY, 2002, 1 (01) :45-54
[8]  
Breinbauer R, 2002, ANGEW CHEM INT EDIT, V41, P2879
[9]   Sequencing the entire genomes of free-living organisms: The foundation of pharmacology in the new millennium [J].
Broder, S ;
Venter, JC .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2000, 40 :97-132
[10]   The use and analysis of microarray data [J].
Butte, A .
NATURE REVIEWS DRUG DISCOVERY, 2002, 1 (12) :951-960